Literature DB >> 15255192

Metalloproteases with EGF, CUB, and thrombospondin-1 domains function in molting of Caenorhabditis elegans.

Mami Suzuki1, Noriko Sagoh, Hideki Iwasaki, Hideshi Inoue, Kenji Takahashi.   

Abstract

Functional analysis using RNAi was performed on eleven genes for metalloproteases of the M12A family in Caenorhabditis elegans and the interference of the C17G1.6 gene (nas-37) was found to cause incomplete molting. The RNAi of the C26C6.3 gene (nas-36) also caused a similar molting defect but not so severely as that of the nas-37 gene. Both the genes encode an astacin-like metalloprotease with an epidermal growth factor (EGF)-like domain, a CUB domain, and a thrombospondin-1 domain, in this order. The promoter-driven green fluorescent protein (GFP) expression analysis suggested that they are expressed in hypodermal cells throughout the larval stages and in the vulva of adult animals. In the genetic background of rde-1(ne219), where RNAi does not work, the molting defect caused by the nas-37 interference was observed when the transgenic wild-type rde-1 gene was expressed under the control of the dpy-7 promoter, known to be active in the hypodermal cells, but not under the control of the myo-3 promoter, active in the muscular cells. Therefore these proteases are thought to be secreted by the hypodermal cells and to participate in shedding of old cuticles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255192     DOI: 10.1515/BC.2004.069

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  22 in total

1.  Establishment of a tissue-specific RNAi system in C. elegans.

Authors:  Hiroshi Qadota; Makiko Inoue; Takao Hikita; Mathias Köppen; Jeffrey D Hardin; Mutsuki Amano; Donald G Moerman; Kozo Kaibuchi
Journal:  Gene       Date:  2007-08-03       Impact factor: 3.688

Review 2.  Molting in C. elegans.

Authors:  Vladimir Lažetić; David S Fay
Journal:  Worm       Date:  2017-05-17

3.  Strongyloides stercoralis excretory/secretory protein strongylastacin specifically recognized by IgE antibodies in infected human sera.

Authors:  Ravi Varatharajalu; Vijayalakshmi Parandaman; Momar Ndao; John F Andersen; Franklin A Neva
Journal:  Microbiol Immunol       Date:  2011-02       Impact factor: 1.955

4.  Lipocalins Are Required for Apical Extracellular Matrix Organization and Remodeling in Caenorhabditis elegans.

Authors:  Rachel Forman-Rubinsky; Jennifer D Cohen; Meera V Sundaram
Journal:  Genetics       Date:  2017-08-25       Impact factor: 4.562

5.  Conserved Ankyrin Repeat Proteins and Their NIMA Kinase Partners Regulate Extracellular Matrix Remodeling and Intracellular Trafficking in Caenorhabditis elegans.

Authors:  Vladimir Lažetić; David S Fay
Journal:  Genetics       Date:  2016-10-31       Impact factor: 4.562

6.  C. elegans NIMA-related kinases NEKL-2 and NEKL-3 are required for the completion of molting.

Authors:  John Yochem; Vladimir Lažetić; Leslie Bell; Lihsia Chen; David Fay
Journal:  Dev Biol       Date:  2014-12-16       Impact factor: 3.582

7.  Identification of novel genes involved in sarcopenia through RNAi screening in Caenorhabditis elegans.

Authors:  Luv Kashyap; Subashan Perera; Alfred L Fisher
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-05-17       Impact factor: 6.053

8.  MLT-10 defines a family of DUF644 and proline-rich repeat proteins involved in the molting cycle of Caenorhabditis elegans.

Authors:  Vijaykumar S Meli; Beatriz Osuna; Gary Ruvkun; Alison R Frand
Journal:  Mol Biol Cell       Date:  2010-03-24       Impact factor: 4.138

9.  RNAi-Mediated Inactivation of Autophagy Genes in Caenorhabditis elegans.

Authors:  Nicholas J Palmisano; Alicia Meléndez
Journal:  Cold Spring Harb Protoc       Date:  2016-02-01

10.  Characterization of the astacin family of metalloproteases in C. elegans.

Authors:  Ja-On Park; Jie Pan; Frank Möhrlen; Marcus-Oliver Schupp; Robert Johnsen; David L Baillie; Richard Zapf; Donald G Moerman; Harald Hutter
Journal:  BMC Dev Biol       Date:  2010-01-28       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.